Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8168090 | 0.87 | CA1 (0.44) | CA1CA2CA7CA9ALDH1A1 | |
| Formaldehyde SCHEMBL8998516 | 0.83 | — | — | |
| Hydrogen Peroxide SCHEMBL11812678 | 0.83 | — | — | |
| SCHEMBL15584 | 0.83 | — | — | |
| SCHEMBL15068452 | 0.83 | CA1 (0.46) | CA1CA2CA7CA9ALDH1A1 | |
| Bicarbonate SCHEMBL1206563 | 0.81 | CA1 (0.41) | CA1CA2CA7CA9ALDH1A1 | |
| Formamide SCHEMBL8516537 | 0.81 | CA1 (0.37) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL547666 | 0.81 | — | — | |
| SCHEMBL4136564 | 0.80 | CA1 (0.44) | CA1CA2CA7CA9ALDH1A1 | |
| Ethylene SCHEMBL8723689 | 0.80 | CA1 (0.40) | CA1CA2CA7CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108348785-B | Composition comprising a metal oxide and a metal oxide | 欧莱雅 | 2021-09-21 | — | — | CN | claimed |
| CN-111978052-B | Concrete with pumice waste residues as aggregate and preparation method thereof | 中国建材检验认证集团股份有限公司 | 2021-04-30 | — | — | CN | claimed |
| CN-111978052-A | Concrete with pumice waste residues as aggregate and preparation method thereof | 中国建材检验认证集团股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-104059170-B | A kind of polymerizable type sweet-smelling formacyl phenyl substituted phosphonates light trigger | Guangzhou Bossin Polymerization Materials Co., Ltd. (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-104059170-A | Polymerizable photo-initiator for substituting phosphonate with aryl formyl phenyl | XINFENG BOXING POLYMERIC MATERIAL CO LTD | 2014-09-24 | — | — | CN | claimed |
| JP-10147507-A | — | — | None | — | — | JP | disclosed |
| EP-4373466-A2 | PIROCTONE PARTICLES FOR USE IN COSMETIC COMPOSITIONS | Clariant International Ltd (CH) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024104987-A2 | PROCESS FOR THE CRYSTALLIZATION OR PRECIPITATION OF PIROCTONE | CLARIANT INTERNATIONAL LTD (CH) | 2024-05-23 | — | — | WO | disclosed |
| US-20240000696-A1 | Opacifier Compositions | CLARIANT INTERNATIONAL LTD. (CH) | 2024-01-04 | — | — | US | disclosed |
| EP-4231991-A1 | OPACIFIER COMPOSITIONS | Clariant International Ltd (CH) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023148138-A1 | COMPOUNDS FOR USE AS HAIR REPAIR AGENTS OR FABRIC REPAIR AGENTS | CLARIANT INTERNATIONAL LTD (CH) | 2023-08-10 | — | — | WO | disclosed |
| EP-3544688-B1 | COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER | CLARIANT INT LTD (CH) | 2023-03-08 | — | — | EP | disclosed |
| US-20040197355-A1 | Cosmetic composition comprising calcuim carbonate particles and a combination of surfactants | L'OREAL (FR) | 2004-10-07 | — | — | US | disclosed |
| US-20030229948-A1 | Composition for the oxidation dyeing of keratin fibres, comprising an oxyalkylenated caboxylic acid ether, a mono-or polyglycerolated surfactant and a nonionic oxyalkylenated surfactant | L'OREAL (FR) | 2003-12-18 | — | — | US | disclosed |
| WO-2003016255-A1 | TOPICAL DEFOAMER AND DEMULSIFIER | CLEARWATER INTERNATIONAL, L.L.C. (US) | 2003-02-27 | — | — | WO | disclosed |
| US-20030036571-A1 | Topical defoamer and demulsifier | Lubrizol Oilfield Solutions, Inc. | 2003-02-20 | — | — | US | disclosed |
| US-6417145-B1 | DETERGENTS AND THICKENERS, CONDITIONERS AND ANIONIC SURFACTANTS | L'OREAL (FR) | 2002-07-09 | — | — | US | disclosed |
| US-6387855-B1 | FOR KERATIN FIBERS | L'OREAL S.A. (FR) | 2002-05-14 | — | — | US | disclosed |
| US-6162423-A | Washing and conditioning compositions containing silicone and dialkyl ether | L'OREAL S.A. (FR) | 2000-12-19 | — | — | US | disclosed |
| US-6159914-A | Detergent cosmetic compositions and use thereof comprising an aminosilicone and a cationic polymer | L'OREAL (FR) | 2000-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197355-A1 | Cosmetic composition comprising calcuim carbonate particles and a combination of surfactants | CALCA, PICALM, CALCR | CA1 98/4885CA2 5/4885CA7 19/4885 |
| US-20240000696-A1 | Opacifier Compositions | CUTA, CRYZ, RAB5IF | CA1 4407/4885CA2 3966/4885CA7 1650/4885 |
| US-20030229948-A1 | Composition for the oxidation dyeing of keratin fibres, comprising an oxyalkylenated caboxylic acid ether, a mono-or polyglycerolated surfactant and a nonionic oxyalkylenated surfactant | KRT18, KRTCAP2, PLOD2 | CA1 1007/4885CA2 380/4885CA7 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.